Aerie Pharmaceuticals (AERI) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AERI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Aerie Pharmaceuticals Short Interest DataCurrent Short Volume1,520,000 sharesPrevious Short Volume1,440,000 sharesChange Vs. Previous Month+5.56%Dollar Volume Sold Short$23.13 millionShort Interest Ratio / Days to Cover1.0Last Record DateOctober 31, 2022Outstanding Shares49,417,000 sharesPercentage of Shares Shorted3.08%Today's Trading Volume600 sharesAverage Trading Volume974,748 sharesToday's Volume Vs. Average0% Short Selling Aerie Pharmaceuticals ? Sign up to receive the latest short interest report for Aerie Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAERI Short Interest Over TimeAERI Days to Cover Over TimeAERI Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Aerie Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20221,520,000 shares $23.13 million +5.6%N/A1 $15.22 10/15/20221,440,000 shares $21.87 million -10.0%N/A0.9 $15.19 9/30/20221,600,000 shares $24.21 million -3.6%N/A1 $15.13 9/15/20221,660,000 shares $25.27 million -24.9%N/A1.1 $15.22 8/31/20222,210,000 shares $33.37 million -36.9%N/A1.5 $15.10 8/15/20223,500,000 shares $41.09 million +1.5%N/A3.1 $11.74 Get the Latest News and Ratings for AERI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerie Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/20223,450,000 shares $24.18 million -7.8%N/A5.1 $7.01 7/15/20223,740,000 shares $29.81 million +3.6%N/A6.1 $7.97 6/30/20223,610,000 shares $27.08 million +10.1%N/A5.7 $7.50 6/15/20223,280,000 shares $21.25 million -19.0%8.1%5.3 $6.48 5/31/20224,050,000 shares $20.98 million -24.6%N/A6 $5.18 5/15/20225,370,000 shares $36.57 million -4.6%N/A6.9 $6.81 4/30/20225,630,000 shares $40.03 million -1.4%12.1%7.3 $7.11 4/15/20225,710,000 shares $52.30 million -2.4%12.3%7 $9.16 3/31/20225,850,000 shares $53.24 million +3.2%12.6%6.6 $9.10 3/15/20225,670,000 shares $46.66 million +5.6%12.2%5.6 $8.23 2/28/20225,370,000 shares $44.57 million +2.1%11.6%4.7 $8.30 2/15/20225,260,000 shares $35.14 million +12.4%11.6%4.4 $6.68 1/31/20224,680,000 shares $34.44 million +2.4%10.3%4.2 $7.36 1/15/20224,570,000 shares $34.50 million +33.2%10.1%4.1 $7.55 12/31/20213,430,000 shares $24.08 million -23.4%7.6%3 $7.02 12/15/20214,480,000 shares $37.68 million +25.8%9.9%4.3 $8.41 11/30/20213,560,000 shares $35.96 million -16.6%7.8%3.5 $10.10 11/15/20214,270,000 shares $49.66 million -26.4%9.4%5.3 $11.63 10/29/20215,800,000 shares $61.65 million -14.3%12.7%8 $10.63 10/15/20216,770,000 shares $89.57 million -6.2%14.9%10 $13.23 9/30/20217,220,000 shares $82.31 million +36.0%15.9%11.9 $11.40 9/15/20215,310,000 shares $83.37 million +5.8%11.7%9 $15.70 8/31/20215,020,000 shares $74.85 million -3.8%11.0%12.2 $14.91 8/13/20215,220,000 shares $76.73 million +0.6%11.5%11.7 $14.70 7/30/20215,190,000 shares $81.90 million -3.4%11.5%10.9 $15.78 7/15/20215,370,000 shares $82.16 million -11.8%11.9%10.8 $15.30 6/30/20216,090,000 shares $97.50 million -6.9%13.5%12 $16.01 6/15/20216,540,000 shares $103.27 million +0.9%14.5%12.9 $15.79 5/28/20216,480,000 shares $105.56 million +2.9%14.4%13.6 $16.29 5/14/20216,300,000 shares $112.58 million -6.0%14.0%11.3 $17.87 4/30/20216,700,000 shares $116.38 million +3.7%14.9%11.9 $17.37 4/15/20216,460,000 shares $118.48 million -7.6%14.4%9.7 $18.34 3/31/20216,990,000 shares $124.56 million -0.9%15.5%10 $17.82 3/15/20217,050,000 shares $147.35 million -3.7%15.7%9.9 $20.90Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> AERI Short Interest - Frequently Asked Questions What is Aerie Pharmaceuticals' current short interest? Short interest is the volume of Aerie Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 1,520,000 shares of AERI short. Learn More on Aerie Pharmaceuticals' current short interest. What is a good short interest ratio for Aerie Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AERI shares currently have a short interest ratio of 1.0. Learn More on Aerie Pharmaceuticals's short interest ratio. Is Aerie Pharmaceuticals' short interest increasing or decreasing? Aerie Pharmaceuticals saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 1,520,000 shares, an increase of 5.6% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aerie Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Aerie Pharmaceuticals: CARGO Therapeutics, Inc. (13.21%), Relay Therapeutics, Inc. (8.08%), REGENXBIO Inc. (8.30%), Cullinan Oncology, Inc. (6.38%), Mesoblast Limited (0.63%), Cabaletta Bio, Inc. (21.09%), HilleVax, Inc. (2.83%), Immatics (10.60%), BioCryst Pharmaceuticals, Inc. (16.68%), Novavax, Inc. (31.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.81 billion), Charter Communications, Inc. ($3.04 billion), T. Rowe Price Group, Inc. ($1.98 billion), PG&E Co. ($1.92 billion), Lucid Group, Inc. ($1.90 billion), Coinbase Global, Inc. ($1.75 billion), Roblox Co. ($1.58 billion), Rivian Automotive, Inc. ($1.54 billion), Diamondback Energy, Inc. ($1.53 billion), and Old Dominion Freight Line, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Aerie Pharmaceuticals stock? Short selling AERI is an investing strategy that aims to generate trading profit from Aerie Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aerie Pharmaceuticals? A short squeeze for Aerie Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AERI, which in turn drives the price of the stock up even further. How often is Aerie Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AERI, twice per month. The most recent reporting period available is October, 31 2022. More Short Interest Resources from MarketBeat Related Companies: CRGX Short Interest RLAY Short Interest RGNX Short Interest CGEM Short Interest MESO Short Interest CABA Short Interest HLVX Short Interest IMTX Short Interest BCRX Short Interest NVAX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AERI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics